If you have been reading about lyophilisation and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Recommended storage for reference material is a freezer at approximately -20 degrees Celsius, protected from light and moisture. Commercial injectable presentations are stored refrigerated between 2 and 8 degrees Celsius and must not be frozen. Product labelling generally permits a limited period at controlled room temperature once dispensed, with the exact window depending on the presentation. Repeated temperature cycling is avoided because it can promote aggregation or deamidation of the peptide chain.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, with mass confirmation by electrospray ionisation mass spectrometry. Peptide mapping after enzymatic digestion verifies the primary sequence. Size-exclusion chromatography quantifies aggregates, while circular dichroism provides a secondary-structure fingerprint. Bioanalytical quantification in plasma uses immunoassay or LC-MS/MS. Reported purity for research-grade lots is commonly 95 percent or higher, and residual water content is checked by Karl Fischer titration.
As a peptide, tirzepatide is handled as a lyophilised solid in research settings and as a preserved solution in finished products. Aqueous solubility is pH dependent and reaches a minimum near the isoelectric point, which lies close to pH 5.4. Stock solutions are typically prepared in neutral or slightly basic buffer to limit precipitation. The solid is hygroscopic and should be equilibrated to room temperature before opening so that condensation does not form on the powder surface.
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
| Property | Value | Notes |
|---|---|---|
| Appearance | white to off-white powder | Lyophilised solid form |
| Solubility | pH dependent; low near pI | Minimum close to pH 5.4 |
| Storage temperature | -20 C solid; 2-8 C solution | Protect from light |
| Isoelectric point | approx. pH 5.4 | Controls solubility minimum |
| Common analytical method | RP-HPLC with mass detection | Purity and identity checks |
Pharmacologically, tirzepatide activates two distinct G protein-coupled receptors: the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Binding at each target triggers cyclic AMP accumulation and downstream signaling in pancreatic beta cells, adipose tissue and the central nervous system. Because the two pathways overlap only partially, the combined effect on insulin secretion, glucagon suppression and appetite signaling differs from that of selective single-receptor compounds. Affinity is not equal across the two targets, and the clinical meaning of that imbalance remains an area of active study.
Clinical research programs have evaluated tirzepatide in adults with type 2 diabetes and in adults with obesity or excess weight. Trials generally reported reductions in glycated hemoglobin and body weight across treatment periods of several months. Since these studies enrolled defined populations under controlled conditions, the findings describe group averages rather than individual outcomes. Open questions include the durability of effects after treatment stops, variation among subgroups, and the long-term consequences of sustained dual receptor stimulation. Published trial summaries should be consulted for exact measurements rather than secondary accounts.
Identity and purity are established with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry for confirmation of the expected mass. Peptide mapping after enzymatic digestion verifies the primary sequence and detects substitutions. Size-exclusion chromatography quantifies aggregates and fragments, which are the impurities most often tracked for peptides of this size. Residual solvents, counterions, and water content fall under separate tests described in pharmacopeial chapters. Circular dichroism or nuclear magnetic resonance may be used in research settings to probe secondary structure, though such methods are less common in routine release testing.
Peptide active ingredients of this type are typically supplied as lyophilized powder because the dry form resists hydrolysis during transport. The material is hygroscopic, so vials are usually equilibrated to room temperature before opening to avoid condensation on the solid. Repeated freeze-thaw cycles can promote aggregation and are generally avoided by aliquoting stock into single-use portions. Personnel handling the powder work in controlled environments to limit inhalation of fine particles. Written procedures usually specify these steps rather than leaving them to individual judgment.
Tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor, making it a dual agonist rather than a selective agent. Engagement of the GLP-1 receptor is linked to glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. The relative contribution of the GIP arm remains an active research question; proposed roles include improved insulin sensitivity and altered adipose tissue handling. Receptor occupancy studies suggest the molecule interacts with both targets at circulating concentrations achieved during therapy.
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
The peptide backbone contains 39 amino acids and includes alpha-aminoisobutyric acid residues, which are not among the standard proteinogenic set. A C20 fatty diacid moiety is attached through a linker, allowing the compound to bind serum albumin and extend its circulation time. This albumin binding is the main reason the molecule supports once-weekly administration rather than more frequent dosing. The measured molecular mass is approximately 4,813 daltons, placing it firmly in the peptide rather than small-molecule class.
Tirzepatide is a synthetic peptide that activates both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual agonist profile distinguishes it from earlier incretin-based compounds that act on a single receptor. The molecule was engineered from the native GIP sequence and carries several non-natural residues that slow enzymatic breakdown. Researchers designed it to combine the insulinotropic effects of GIP signaling with the appetite and gastric-emptying effects associated with GLP-1 activation.
Somorjai (born 1935), 1998 Wolf Prize in Chemistry Georg Ernst Stahl (1659–1734), Important work on fermentation Wendell Meredith Stanley (1904–1971), 1946 Nobel Prize in Chemistry Jean Servais Stas (1813–1891), Belgian analytical chemist Branko Stanovnik (born 1938), chemist Hermann Staudinger (1881–1965), polymer chemist, 1953 Nobel Prize in Chemistry Harry Steenbock (1886–1967), American biochemist, worked on ultraviolet irradiation William Howard Stein (1911–1980), 1972 Nobel Prize in Chemistry Thomas A. Steitz (1940–2018), 2009 Nobel Prize in Chemistry Douglas Stephan, Frustrated Lewis Pairs Rose Stern (1869–1953), first British woman member of the Royal Institute of Chemistry Alfred Stock (1876–1946), German inorganic chemist, known for work in mercury poisoning Brian Stoltz (born 1970), award-winning American organic chemist. Fraser Stoddart (1942–2024), Scottish chemist, a pioneer in the field of the mechanical bond Molly Shoichet, award-winning Canadian biomedical engineer known for her work in tissue engineering. She is the only person to be a fellow of the three National Academies in Canada F. Gordon A. Stone (1925–2011), British inorganic chemist S. Donald Stookey (1915–2014), American glass and ceramic chemist Gilbert Stork (1921–2017), 1995/6 Wolf Prize in Chemistry Friedrich August Kekulé von Stradonitz (1829–1896), German organic chemist, principal founder of chemical structure Yellapragada Subbarow (1895-1948), Indian biochemist known for discovery of ATP and synthesis of many new ground breaking compounds James B.
Peritoneal ligament: a fold of peritoneum or other membranes. Fetal remnant ligament: the remnants of a fetal tubular structure. Periodontal ligament: a group of fibers that attach the cementum of teeth to the surrounding alveolar bone.
== History == Creatine was first identified in 1832 when Michel Eugène Chevreul isolated the precipitate from the basified water-extract of skeletal muscle. He later named the crystallized precipitate after the Greek word for meat, κρέας (kreas). In 1928, creatine was shown to exist in equilibrium with creatinine. Studies in the 1920s showed that consumption of large amounts of creatine did not result in its excretion. This result pointed to the ability of the body to store creatine, which in turn suggested its use as a dietary supplement. In 1912, Harvard University researchers Otto Folin and Willey Glover Denis found evidence that ingesting creatine can dramatically boost the creatine content of the muscle. The discovery of phosphocreatine was reported in 1927. In the 1960s, the enzyme creatine kinase was shown to phosphorylate ADP using phosphocreatine to generate ATP and thus buffering the ATP/ADP ratio. While creatine's influence on physical performance has been well documented since the early twentieth century, it came into public view following the 1992 Olympics in Barcelona. An 7 August 1992 article in The Times reported that Linford Christie, the gold medal winner at 100 metres, had used creatine before the Olympics. An article in Bodybuilding Monthly named Sally Gunnell, who was the gold medalist in the 400-metre hurdles, as another creatine user. In addition, The Times also noted that 110 metre hurdler Colin Jackson began taking creatine before the Olympics.
== Overview of the carbon fixation cycles == Seven autotrophic carbon fixation pathways are known: the Calvin Cycle, the Reverse Krebs Cycle, the reductive acetyl-CoA, the 3-HP bicycle, the 3-HP/4-HB cycle, the DC/4-HB cycles, and the reductive glycine pathway.
=== Hypersensitivity reaction === Lichenoid reaction: Intra-oral lesion which shares the appearance of lichen planus but arises due to contact hypersensitivity to certain dental materials or drug-induced.
Sources: en.wikipedia.org
Binds to the progesterone receptor (PR) and to an unidentified membrane receptor that drives Prostaglandin E2 (PGE₂) synthesis via COX-2 induction. Induces a feed-forward loop in which PGE₂ amplifies BMP2 expression, accelerating osteogenic and chondrogenic differentiation. Causes sustained phosphorylation of PKCε, an isoform linked to suppression of the hypertrophic cartilage marker MATN1 and to formation of articular-cartilage (interzone) phenotypes. Pharmacological blockade of either PR (mifepristone) or COX-2 (indomethacin) abolishes these effects, confirming that stanozolol’s osteochondral activity requires simultaneous PR signaling and PGE₂-driven crosstalk with the BMP2 pathway. Additionally, stanozolol has been shown to exert activity via estrogen receptor alpha (ERα) in vivo. In a rat model of GnRH agonist-induced growth plate suppression, stanozolol restored chondrocyte proliferation via ERα activation, indicating selective estrogen receptor-mediated effects in growth plate cartilage.
In the skull, a supratemporal fossa (excavation) is present in front of the supratemporal fenestra, the main opening in the rear skull roof Epipophyses, obliquely backward-pointing processes on the rear top corners of the anterior (front) neck vertebrae behind the atlas and axis, the first two neck vertebrae Apex of a deltopectoral crest (a projection on which the deltopectoral muscles attach) located at or more than 30% down the length of the humerus (upper arm bone) Radius, a lower arm bone, shorter than 80% of humerus length Fourth trochanter (projection where the caudofemoralis muscle attaches on the inner rear shaft) on the femur (thigh bone) is a sharp flange Fourth trochanter asymmetrical, with distal, lower, margin forming a steeper angle to the shaft On the astragalus and calcaneum, upper ankle bones, the proximal articular facet, the top connecting surface, for the fibula occupies less than 30% of the transverse width of the element Exoccipitals (bones at the back of the skull) do not meet along the midline on the floor of the endocranial cavity, the inner space of the braincase In the pelvis, the proximal articular surfaces of the ischium with the ilium and the pubis are separated by a large concave surface (on the upper side of the ischium a part of the open hip joint is located between the contacts with the pubic bone and the ilium) Cnemial crest on the tibia (protruding part of the top surface of the shinbone) arcs anterolaterally (curves to the front and the outer side) Distinct proximodistally oriented (vertical) ridge present on the posterior face of the distal end of the tibia (the rear surface of the lower end of the shinbone) Concave articular surface for the fibula of the calcaneum (the top surface of the calcaneum, where it touches the fibula, has a hollow profile) Nesbitt found a number of further potential synapomorphies and discounted a number of synapomorphies previously suggested. Some of these are also present in silesaurids, which Nesbitt recovered as a sister group to Dinosauria, including a large anterior trochanter, metatarsals II and IV of subequal length, reduced contact between ischium and pubis, the presence of a cnemial crest on the tibia and of an ascending process on the astragalus, and many others.
This means that the signal can be measured by an oscilloscope in trigger mode. Indeed, the first GC-MS was done in 1950 using an oscilloscope. The experimenters took quick photos of the oscilloscope screen for each component exiting the gas chromatography machine. This distribution in velocities broadens the peaks shown on the count vs m/z plot, but will generally not change the central location of the peaks, since the starting velocity of ions is generally centered at zero. To fix this problem, time-lag focusing/delayed extraction has been coupled with TOF-MS. If the ions do not start at identical kinetic energies, then some ions may lag behind higher kinetic energy ions decreasing resolution. Reflectron geometries are commonly employed to correct this problem. Longer tubes result in higher resolution. A reflector doubles the effective tube length. A reflector-TOF can reach a resolution of several thousands. For their low resolution, TOF mass spectrometers makes up for it in speed. They are particularly useful in chemical kinetics studies. It can study rapid reactions such as combustion and explosions.
== General characteristics == Pseudomonas fluorescens has multiple flagella, an extremely versatile metabolism, and can be found in the soil and in water. It is an obligate aerobe, but certain strains are capable of using nitrate instead of oxygen as a final electron acceptor during cellular respiration. Optimal temperatures for growth of P. fluorescens are 25–30°C. It tests positive for the oxidase test, and is also a nonsaccharolytic bacterial species. Heat-stable lipases and proteases are produced by P. fluorescens and other similar pseudomonads. These enzymes cause milk to spoil, by causing bitterness, casein breakdown, and ropiness due to production of slime and coagulation of proteins.
Sources: en.wikipedia.org
Hong Kong has two theme parks. Hong Kong Disneyland on Lantau Island is a major theme park and resort destination. Ocean Park Hong Kong combines rides and animal exhibits, with zones across the Waterfront and Summit areas. For big events, Kai Tak Sports Park anchors the city's newest entertainment hub, built on the former airport site, with a 50,000-seat main stadium and a retractable roof. Hong Kong Stadium remains a key venue for football and major fixtures in Causeway Bay, with a capacity of 40,116. AsiaWorld-Expo near the airport hosts concerts, exhibitions, and large-scale conventions across multiple halls and an arena-style space. Hong Kong Convention and Exhibition Centre is the core waterfront venue in Wan Chai for exhibitions, meetings, and shows.
== Early life == Nayib Armando Bukele Ortez was born on 24 July 1981 in San Salvador, El Salvador. His father was Armando Bukele Kattán, a businessman and industrial chemist, and his mother is Olga Marina Ortez. Bukele's father died in 2015. Bukele was the couple's first child. He has three younger brothers, Karim, Yusef, and Ibrajim, and has four paternal half-sisters and two paternal half-brothers. Bukele's father converted from Christianity to Islam in the 1980s, became an imam, and founded four mosques in El Salvador. Bukele's mother is Catholic. Bukele's paternal grandparents were Palestinian Christians who emigrated to El Salvador from Jerusalem and Bethlehem in 1921. His maternal grandfather was Greek Orthodox, and his maternal grandmother was Catholic. Bukele completed his secondary education at the Escuela Panamericana in 1999 at age 18. Bukele enrolled at Central American University in San Salvador to study legal sciences, aspiring to become a lawyer, but dropped out to work for the Nölck advertising agency, one of his father's businesses. Nölck campaigned for the Farabundo Martí National Liberation Front (FMLN), a left-wing Salvadoran political party. In 1999, Bukele founded the marketing company Obermet, also known as 4am Saatchi & Saatchi El Salvador, and was its president from 1999 to 2006 and from 2010 to 2012. The company ran political advertising for the FMLN presidential campaigns of Schafik Hándal in 2004 and Mauricio Funes in 2009.
May 13–15 – President Trump makes a state visit to China and meets with Chinese leader Xi Jinping. May 13 – The U.S. Senate confirms Kevin Warsh as the Chair of the Federal Reserve in a 54–45 vote. Warsh will succeed Jerome Powell at the end of the latter's term. May 14 Federal employees sue USDA and Secretary Brooke Rollins on First Amendment grounds over proselytizing Christian messaging in work emails. Mike Banks resigns as U.S. Border Patrol Chief, saying he wanted to spend time with family. Bank's resignation came weeks after the Washington Examiner alleged that he engaged in sex tourism in Colombia and Thailand. May 16 – 2026 Long Island Rail Road strike: Five unions representing over 3,500 workers for the Long Island Rail Road, the largest commuter rail system in North America, go on strike to negotiate a new contract with the Metropolitan Transportation Authority in New York City. May 18 – Five people, including two gunmen, are killed in a mass shooting at a mosque in San Diego, California. May 18–19 – The DOJ announces they reached a settlement with the Internal Revenue Service to resolve Trump's $10 billion lawsuit regarding the 2020 leak of his tax returns to The New York Times. Trump drops the lawsuit but will receive a $1.776 billion "anti-weaponization fund" to give to people who were prosecuted by the Biden administration. A day later, the DOJ reveals that the settlement terms include that the IRS is "forever barred and precluded" from investigating past tax returns filed by President Trump, his family and his businesses. May 19 – U.S.
ASBMB hosts and sponsors numerous meetings each year. The annual meeting is held each April in conjunction with the Experimental Biology meeting. Additionally, themed special symposia are organized throughout the year. The society also produces webinars throughout the year focused on topics related to scientific research, professional development and education. The society offers twenty-five different awards, grants, and scholarships.
Counter-Strike: Global Offensive is the fourth release in the main, Valve-developed Counter-Strike series in 2012. Much like Counter-Strike: Source the game runs on the Source engine. It is available for Microsoft Windows, OS X, and Linux, as well as the Xbox 360 and PlayStation 3 consoles, and is backwards compatible on the Xbox One console.
Sources: en.wikipedia.org
Solid material is normally kept frozen at about -20 degrees Celsius, desiccated and protected from light. Solutions are held cold and used within a defined window because degradation products accumulate over time.
Mass spectrometry, usually electrospray ionisation coupled to liquid chromatography, gives an observed mass for comparison with the theoretical value. Peptide mapping after digestion provides complementary sequence-level confirmation.
Short exposure during weighing and handling is generally tolerated, but prolonged storage above refrigerated conditions raises the risk of deamidation, oxidation, and aggregation. The rate depends on pH, buffer composition, and concentration.
It acts as an agonist at both the GIP and GLP-1 receptors, two related class B G protein-coupled receptors. This dual activity distinguishes it from single-receptor GLP-1 agonists. The clinical consequences of engaging both receptors are still being characterized.